Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $8,406 - $10,143
-24 Reduced 3.16%
736 $263,000
Q2 2023

Aug 15, 2023

BUY
$359.49 - $486.4 $21,209 - $28,697
59 Added 8.42%
760 $288,000
Q1 2023

May 03, 2023

BUY
$418.69 - $503.0 $293,501 - $352,603
701 New
701 $336,000
Q3 2022

Oct 31, 2022

BUY
$412.59 - $563.26 $47,447 - $64,774
115 Added 22.95%
616 $257,000
Q1 2022

May 12, 2022

BUY
$524.57 - $735.42 $13,638 - $19,120
26 Added 5.47%
501 $283,000
Q4 2021

Jan 31, 2022

BUY
$708.84 - $794.68 $33,315 - $37,349
47 Added 10.98%
475 $359,000
Q3 2021

Oct 18, 2021

SELL
$657.71 - $825.77 $11,181 - $14,038
-17 Reduced 3.82%
428 $319,000
Q2 2021

Jul 20, 2021

SELL
$576.64 - $649.04 $16,145 - $18,173
-28 Reduced 5.92%
445 $286,000
Q1 2021

May 03, 2021

BUY
$547.01 - $662.35 $258,735 - $313,291
473 New
473 $270,000
Q4 2018

Jan 29, 2019

SELL
$220.1 - $309.0 $169,697 - $238,239
-771 Closed
0 $0
Q3 2018

Oct 16, 2018

BUY
$289.28 - $326.15 $10,414 - $11,741
36 Added 4.9%
771 $241,000
Q2 2018

Jul 11, 2018

BUY
$244.1 - $303.88 $179,413 - $223,351
735 New
735 $212,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.